EGFR and neoplasm: Taken together, these findings indicate that interaction of IL-26 and EphA3 induces increased phosphorylation of AKT and JNK not only in murine TNBC but also in human TNBC, hence activating the EGFR-TKI-associated bypass pathway to result subsequently in tumor growth.